[ANABOLIC DRUGS IN THE CORRECTION OF A PROTEIN-DEFICIENT NUTRITIONAL STATE. BIOPHARMACOLOGICAL AND CLINICAL CONSIDERATIONS ON THE USE OF 2-ALPHA,17-ALPHA-DIMETHYL-5-ALPHA-ANDROSTAN-17-BETA-OL-3,3'-AZINE (DIMETHAZINE)].
D045930:Anabolic Agents; D000732:Androstanols; D000740:Anemia; D000747:Anemia, Hypochromic; D001168:Arthritis; D001172:Arthritis, Rheumatoid; D035843:Biomedical Research; D001797:Blood Protein Electrophoresis; D001991:Bronchitis; D004696:Endocarditis; D004697:Endocarditis, Bacterial; D005759:Gastroenteritis; D008103:Liver Cirrhosis; D008169:Lung Abscess; D008175:Lung Neoplasms; D011488:Protein Deficiency; D012709:Serum Albumin; D013256:Steroids; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D045930:Anabolic Agents; D000732:Androstanols; D012709:Serum Albumin; D013256:Steroids; C000658:androstan-3-ol; C010216:mebolazine
ANABOLIC STEROIDS; ANEMIA, HYPOCHROMIC; ARTHRITIS, RHEUMATOID; BLOOD PROTEIN ELECTROPHORESIS; BRONCHITIS; CLINICAL RESEARCH; ENDOCARDITIS, BACTERIAL; GASTROENTERITIS; LIVER CIRRHOSIS; LUNG ABSCESS; LUNG NEOPLASMS; PROTEIN DEFICIENCY; SERUM ALBUMIN; TUBERCULOSIS, PULMONARY
I FARMACI ANABOLIZZANTI NELLA CORREZIONE DI UNO STATO NUTRIZIONALE PROTEICO DEFICITARIO. CONSIDERAZIONI BIO-FARMACOLOGICHE E CLINICHE SULL'IMPIEGO DELLA 2-ALPHA, 17-ALPHA-DIMETIL-5-ALPHA-ANDROSTAN-17-BETA-OL-3,3'-AZINA (DIMETAZINA)